Literature DB >> 25211270

MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study.

Doenja M J Lambregts1, Sheng-Xiang Rao, Sander Sassen, Milou H Martens, Luc A Heijnen, Jeroen Buijsen, Meindert Sosef, Geerard L Beets, Roy A Vliegen, Regina G H Beets-Tan.   

Abstract

BACKGROUND: Retrospective single-center studies have shown that diffusion-weighted magnetic resonance imaging (DWI) is promising for identification of patients with rectal cancer with a complete tumor response after neoadjuvant chemoradiotherapy (CRT), using certain volumetric thresholds.
OBJECTIVE: This study aims to validate the diagnostic value of these volume thresholds in a larger, independent, and bi-institutional patient cohort.
METHODS: A total of 112 patients with locally advanced rectal cancer (2 centers) treated with a long course of CRT were enrolled. Patients underwent standard T2W-magnetic resonance imaging and DWI, both pre- and post-CRT. Two experienced readers independently determined pre-CRT and post-CRT tumor volumes (cm) on T2W-magnetic resonance image and diffusion-weighted magnetic resonance image by means of freehand tumor delineation. Tumor volume reduction rates (Δvolume) were calculated. Previously determined T2W and DWI threshold values for prevolume, postvolume, and Δvolume were tested to "prospectively" assess their respective diagnostic value in discriminating patients with a complete tumor response from patients with residual tumor.
RESULTS: Twenty patients had a complete response. Using the average measurements between the 2 readers, areas under the curve for the pre-/post-/Δvolumes was 0.73/0.82/0.78 for T2W-magnetic resonance imaging and 0.77/0.92/0.86 for DWI, respectively. For T2W-volumetry, sensitivity and specificity using the predefined volume thresholds were 55% and 74% for pre-, 60% and 89% for post-, and 60% and 86% for Δvolume. For DWI volumetry, sensitivity and specificity were 65% and 76% for pre-, 70% and 98% for post-, and 70% and 93% for Δvolume.
CONCLUSIONS: Previously established DWI volume thresholds can be reproduced with good results. Post-CRT DWI volumetry offers the best results for the detection of patients with a complete response after CRT with an area under the curve of 0.92, sensitivity of 70%, and specificity of 98%.

Entities:  

Mesh:

Year:  2015        PMID: 25211270     DOI: 10.1097/SLA.0000000000000909

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  29 in total

1.  T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer.

Authors:  Sungwon Kim; Kyunghwa Han; Nieun Seo; Hye Jin Kim; Myeong-Jin Kim; Woong Sub Koom; Joong Bae Ahn; Joon Seok Lim
Journal:  Eur Radiol       Date:  2018-06-01       Impact factor: 5.315

2.  Intravoxel Incoherent Motion-derived Histogram Metrics for Assessment of Response after Combined Chemotherapy and Radiation Therapy in Rectal Cancer: Initial Experience and Comparison between Single-Section and Volumetric Analyses.

Authors:  Stephanie Nougaret; Hebert Alberto Vargas; Yulia Lakhman; Romain Sudre; Richard K G Do; Frederic Bibeau; David Azria; Eric Assenat; Nicolas Molinari; Marie-Ange Pierredon; Philippe Rouanet; Boris Guiu
Journal:  Radiology       Date:  2016-02-26       Impact factor: 11.105

Review 3.  Diffusion-weighted imaging in rectal cancer: current applications and future perspectives.

Authors:  Niels W Schurink; Doenja M J Lambregts; Regina G H Beets-Tan
Journal:  Br J Radiol       Date:  2019-03-05       Impact factor: 3.039

4.  Feasibility evaluation of diffusion-weighted imaging using an integrated MRI-radiotherapy system for response assessment to neoadjuvant therapy in rectal cancer.

Authors:  Narek Shaverdian; Yingli Yang; Peng Hu; Steven Hart; Ke Sheng; James Lamb; Minsong Cao; Nzhde Agazaryan; David Thomas; Michael Steinberg; Daniel A Low; Percy Lee
Journal:  Br J Radiol       Date:  2017-01-12       Impact factor: 3.039

5.  Accuracy and feasibility of estimated tumour volumetry in primary gastric gastrointestinal stromal tumours: validation using semiautomated technique in 127 patients.

Authors:  Sree Harsha Tirumani; Atul B Shinagare; Ailbhe C O'Neill; Mizuki Nishino; Michael H Rosenthal; Nikhil H Ramaiya
Journal:  Eur Radiol       Date:  2015-05-20       Impact factor: 5.315

6.  Changes in the multidisciplinary management of rectal cancer from 2009 to 2015 and associated improvements in short-term outcomes.

Authors:  C S D Roxburgh; P Strombom; P Lynn; A Cercek; M Gonen; J J Smith; L K F Temple; G M Nash; J G Guillem; P B Paty; J Shia; E Vakiani; R Yaeger; Z K Stadler; N H Segal; D Reidy; A Varghese; A J Wu; C H Crane; M J Gollub; L B Saltz; J Garcia-Aguilar; M R Weiser
Journal:  Colorectal Dis       Date:  2019-07-01       Impact factor: 3.788

7.  MR Imaging of Rectal Cancer: Radiomics Analysis to Assess Treatment Response after Neoadjuvant Therapy.

Authors:  Natally Horvat; Harini Veeraraghavan; Monika Khan; Ivana Blazic; Junting Zheng; Marinela Capanu; Evis Sala; Julio Garcia-Aguilar; Marc J Gollub; Iva Petkovska
Journal:  Radiology       Date:  2018-03-07       Impact factor: 11.105

8.  Value of combined multiparametric MRI and FDG-PET/CT to identify well-responding rectal cancer patients before the start of neoadjuvant chemoradiation.

Authors:  Niels W Schurink; Lisa A Min; Maaike Berbee; Wouter van Elmpt; Joost J M van Griethuysen; Frans C H Bakers; Sander Roberti; Simon R van Kranen; Max J Lahaye; Monique Maas; Geerard L Beets; Regina G H Beets-Tan; Doenja M J Lambregts
Journal:  Eur Radiol       Date:  2020-02-07       Impact factor: 5.315

9.  Development and validation of an MRI-based model to predict response to chemoradiotherapy for rectal cancer.

Authors:  Philippe Bulens; Alice Couwenberg; Karin Haustermans; Annelies Debucquoy; Vincent Vandecaveye; Marielle Philippens; Mu Zhou; Olivier Gevaert; Martijn Intven
Journal:  Radiother Oncol       Date:  2018-01-31       Impact factor: 6.280

10.  Pelvic MRI after induction chemotherapy and before long-course chemoradiation therapy for rectal cancer: What are the imaging findings?

Authors:  Marc J Gollub; Ivana Blazic; David D B Bates; Naomi Campbell; Andrea Knezevic; Mithat Gonen; Patricio Lynn; Martin R Weiser; Julio Garcia-Aguilar; Andreas M Hötker; Andrea Cercek; Leonard Saltz
Journal:  Eur Radiol       Date:  2018-10-02       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.